Vyluma to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023 07:00 ET
|
Vyluma, Inc.
BRIDGEWATER, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Vyluma, Inc. (“Vyluma”), a biopharmaceutical company developing multiple assets for the treatment of refractive errors, today announced it...